Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JANET PAN

NPI
1801056676
CMS profile
354136
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$6,396.31

346 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $6,034.39 342
Education $361.92 4

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $513.25 26
Incyte Corporation $441.93 20
Janssen Biotech, Inc. $360.99 20
Novartis Pharmaceuticals Corporation $347.21 21
Celgene Corporation $343.98 25
Seagen Inc. $342.81 17
Astellas Pharma US Inc $246.91 11
E.R. Squibb & Sons, L.L.C. $236.66 22
EISAI INC. $219.63 9
Merck Sharp & Dohme LLC $219.26 11
Pharmacyclics LLC, an AbbVie Company $193.85 14
Amgen Inc. $182.68 11
Lilly USA, LLC $172.16 8
Gilead Sciences, Inc. $158.28 8
ARRAY BIOPHARMA INC $141.40 9
PFIZER INC. $135.82 11
Exelixis Inc. $132.70 5
PUMA BIOTECHNOLOGY, INC. $131.58 7
Genentech USA, Inc. $129.62 6
Myovant Sciences Inc. $124.75 9
MorphoSys, US Inc. $112.12 6
GlaxoSmithKline, LLC. $108.27 5
SANOFI-AVENTIS U.S. LLC $99.95 1
Coherus Biosciences Inc. $91.05 5
Blueprint Medicines Corporation $89.96 3
Daiichi Sankyo Inc. $89.69 4
Bayer HealthCare Pharmaceuticals Inc. $66.61 4
Kite Pharma, Inc. $66.04 4
Deciphera Pharmaceuticals Inc. $63.30 3
GENZYME CORPORATION $57.69 3
BeiGene USA, Inc. $56.68 3
EMD Serono, Inc. $56.58 3
AVEO Pharmaceuticals, Inc. $54.57 2
SERVIER PHARMACEUTICALS LLC $48.57 2
Octapharma USA, Inc. $46.82 2
Adaptive Biotechnologies Corporation $45.06 2
ABBVIE INC. $42.45 2
Boehringer Ingelheim Pharmaceuticals, Inc. $35.64 2
Epizyme, Inc., $34.92 2
Takeda Pharmaceuticals U.S.A., Inc. $34.91 1
Karyopharm Therapeutics Inc. $33.66 1
Sobi, Inc $33.54 2
Ipsen Biopharmaceuticals, Inc $30.14 2
Emmaus Medical, Inc. $27.18 2
Regeneron Healthcare Solutions, Inc. $25.08 1
G1 Therapeutics, Inc. $23.21 1
GE HealthCare $22.61 1
TerSera Therapeutics LLC $22.20 1
Pharmacosmos Therapeutics Inc. $21.30 1
Rigel Pharmaceuticals, Inc. $19.13 1
TG Therapeutics, Inc. $17.97 1
Alnylam Pharmaceuticals Inc. $16.97 1
Taiho Oncology, Inc. $14.61 1
Foundation Medicine, Inc. $12.36 1

Page 5 of 7; records 201–250 of 346 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JANET PAN

NPI 1801056676 · CMS profile ID 354136

FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 7; records 201–250 of 346 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1801056676?year=2022&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 346 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1801056676?year=2022&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JANET PAN, NPI 1801056676, CMS profile ID 354136. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 7; records 201–250 of 346 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1801056676?year=2022&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JANET PAN, NPI 1801056676, CMS profile ID 354136, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 7; records 201–250 of 346 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1801056676?year=2022&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

346 matching records · $6,396.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 346 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 346.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $24.9405/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914915057 CMS
Celgene Corporation $19.3505/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932761405 CMS
EMD Serono, Inc. $14.5105/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941516875 CMS
GE HealthCare $22.6105/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953426443 CMS
Janssen Biotech, Inc. $16.4205/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885536589 CMS
Lilly USA, LLC $18.6905/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918081421 CMS
Myovant Sciences Inc. $11.4405/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941230761 CMS
Epizyme, Inc., $17.3505/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917610453 CMS
PUMA BIOTECHNOLOGY, INC. $17.3605/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942289311 CMS
Amgen Inc. $27.0605/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939881201 CMS
Incyte Corporation $26.0405/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943035737 CMS
Deciphera Pharmaceuticals Inc. $19.8705/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953435145 CMS
ABBVIE INC. $19.8805/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891307937 CMS
Novartis Pharmaceuticals Corporation $20.0405/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196307 CMS
Gilead Sciences, Inc. $23.7205/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929557275 CMS
Astellas Pharma US Inc $18.2105/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940182181 CMS
AstraZeneca Pharmaceuticals LP $24.5405/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914947291 CMS
Novartis Pharmaceuticals Corporation $18.0705/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196339 CMS
Seagen Inc. $10.4705/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904091997 CMS
GlaxoSmithKline, LLC. $19.6105/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944779529 CMS
TerSera Therapeutics LLC $22.2005/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943240841 CMS
Novartis Pharmaceuticals Corporation $15.2105/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196335 CMS
Bayer HealthCare Pharmaceuticals Inc. $24.0004/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930603837 CMS
Seagen Inc. $11.7704/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904091983 CMS
Celgene Corporation $10.5304/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932761621 CMS
Janssen Biotech, Inc. $6.2404/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885536601 CMS
AstraZeneca Pharmaceuticals LP $24.9304/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915617351 CMS
Myovant Sciences Inc. $16.3604/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941230759 CMS
Novartis Pharmaceuticals Corporation $9.4504/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196331 CMS
Seagen Inc. $9.6804/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904092029 CMS
EISAI INC. $24.6704/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908044637 CMS
Gilead Sciences, Inc. $17.5504/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929557261 CMS
Lilly USA, LLC $23.4804/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918053933 CMS
PFIZER INC. $19.7804/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949358699 CMS
GlaxoSmithKline, LLC. $23.8704/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944779533 CMS
Merck Sharp & Dohme LLC $22.5804/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944411561 CMS
Exelixis Inc. $26.2304/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932462239 CMS
Kite Pharma, Inc. $19.9404/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920056115 CMS
Daiichi Sankyo Inc. $21.9304/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930819625 CMS
Octapharma USA, Inc. $29.1704/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937556439 CMS
Pharmacyclics LLC, an AbbVie Company $14.6104/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890345315 CMS
E.R. Squibb & Sons, L.L.C. $11.1604/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932761369 CMS
Celgene Corporation $22.6104/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932761615 CMS
E.R. Squibb & Sons, L.L.C. $0.2404/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932761617 CMS
E.R. Squibb & Sons, L.L.C. $10.4404/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932761619 CMS
PUMA BIOTECHNOLOGY, INC. $15.4404/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942295631 CMS
MorphoSys, US Inc. $19.5304/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 962537749 CMS
Epizyme, Inc., $17.5703/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917610447 CMS
Incyte Corporation $24.7903/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943035729 CMS
PUMA BIOTECHNOLOGY, INC. $21.6003/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942301537 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,304.61 322
PY2020 $5,339.64 303
PY2021 $6,218.12 325
PY2022 $6,396.31 346
PY2023 $6,939.00 351
PY2024 $7,888.97 348
PY2025 $8,105.08 333

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $96,505.50 3
PY2024 Principal investigator $13,150.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $14,535.50 11/20/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1235996173
Principal investigator 1 Celgene Corporation $55,585.00 06/25/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306877
Principal investigator 1 Celgene Corporation $26,385.00 04/23/2025 Non-covered Recipient Entity
Los Angeles Cancer Network
A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1222306937